Hemofília: vizsgálatok itt: Franciaország
26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Bron, Le Kremlin Bicetre Cedex, Lille, Paris
- Életkor
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - 3. fázisTaking peopleA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Bron, Le Kremlin-Bicetre, Lille, Nantes
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Paris
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Bron, Le Kremlin Bicetre Cedex, Lille
- Életkor
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - 3. fázisTaking peopleA Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
- Where
- Bron, Paris
- Életkor
- 18 év to 64 év
- People
- 32 worldwide
- Run by
- Pfizer Inc.
See details and how to join2025-523660-21-00 · EU 2025-523660-21-00 - No phaseTaking peopleDevelopment of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
- Where
- Paris
- Életkor
- 18 év and over
- People
- 550
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06147414 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Where
- Bron, Lille, Paris
- Életkor
- 2 év and over
- People
- 130 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06379789 · EU 2023-507260-40-00 - 3. fázisTaking peoplePhase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Where
- Lille, Marseille
- Életkor
- 138 hónap to 206 hónap
- People
- 20 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07080905 · EU 2023-505805-18-00 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Paris
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - No phaseTaking peopleDeterminants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project
- Where
- Annecy, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montmorency, Montpellier, Nancy, Nantes, Paris, Reims, Rennes, Rouen, Saint-Denis, Saint-Etienne, Strasbourg, Toulouse, Versailles
- Életkor
- 20 év to 29 év
- People
- 75
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT07418827 - 3. fázisTaking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Bron, Paris
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - No phaseNot yet taking people in FranciaországEfanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A
- Where
- Angers, Bordeaux, Brest, Caen, Chambray-lès-Tours, Le Mans, Nantes, Rennes
- People
- 553
- Run by
- Nantes University Hospital
See details and how to joinNCT07830693 - 1. fázisTaking peopleA Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Bron
- Életkor
- 18 év to 64 év
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00 - No phaseNot yet taking people in FranciaországUltrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)
- Where
- Paris
- Életkor
- 18 év and over
- People
- 150
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07719647 - No phaseTaking peopleStudy of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)
- Where
- Bron
- People
- 160
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07723560 - 4. fázisTaking peopleNuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
- Where
- Nantes, Strasbourg Cedex 2, Tours
- People
- 17 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502061-17-00 · EU 2022-502061-17-00 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Besançon, Chambéry, Chambray-lès-Tours, Le Mans, Montmorency, Nantes, Paris, Saint-Priest-en-Jarez
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - No phaseTaking peopleSevere Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
- Where
- Lille
- Életkor
- 18 év and over
- People
- 200
- Run by
- University Hospital, Lille
See details and how to joinNCT06090201 - 4. fázisTaking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Nantes, Tours
- Életkor
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - 4. fázisTaking peopleNuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- Where
- Chambray-lès-Tours, Nantes, Stasbourg
- Életkor
- 12 év and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05936580 - No phaseTaking peopleMonitoring of Anti-TFPI in Hemophilia
- Where
- Bron, Paris
- Életkor
- 18 év and over
- People
- 11
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07101926 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Brest, Nantes, Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - 4. fázisCsak meghívásosA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Lille, Marseille
- Életkor
- 18 év and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - No phaseTaking peopleLong-term Anticoagulation in a Patient With Severe Hemophilia A
- Where
- Strasbourg
- Életkor
- 18 év and over
- People
- 1
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07314983 - 4. fázisTaking peopleNuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Nantes, Tours
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00 · EU 2022-502060-21-00